31.05.2025 · DION news

GeneSkin AI wins first prize at VISI Demo Day 2025 and secures an investment commitment

GeneSkin AI, co-founded by Digital Innovation, marked a milestone at VISI Demo Day 2025 with first prize and an early-stage investment agreement.

DION representative at VISI Demo Day on 31 May 2025.
DION representative at VISI Demo Day on 31 May 2025.

A milestone following the incubation journey

GeneSkin AI joined VISI Demo Day at Vietnam National University, Hanoi on 31 May 2025. DION’s team records report that the project won first prize. VISI separately confirms that GeneSkin AI was one of two teams receiving investment commitments after Demo Day.

Digital Innovation co-founded GeneSkin AI. The milestone recognizes the team’s collective effort and opens further opportunities to connect expertise, resources and market perspectives for the next development stage.

GeneSkin AI representatives at the VISI 2025 incubation program’s Demo Day.
GeneSkin AI representatives at the VISI 2025 incubation program’s Demo Day.

The investment agreement and its significance

According to information supplied by DION, the agreement was VND 50 million for a 1% equity stake, implying a VND 5 billion post-money valuation at the seed stage. These are the recorded agreement terms, not a claim that the investment has been fully disbursed.

For an early-stage team, support also means constructive challenge, advice and connections. Demo Day provided an opportunity to present the product direction, respond to questions and identify the work still needed to refine it.

Genetic information and AI for personalized skincare

GeneSkin AI explores combining genetic information with AI to support skincare tailored to individuals. DION contributes its technology development capabilities and an approach grounded in practical user needs.

The team appreciates VISI’s support and the dedication of GeneSkin AI’s members. Beyond Demo Day, the goal is to move the idea toward a useful product while treating data and users responsibly. Skincare support does not replace medical diagnosis or treatment.

Source reporting